FDA Inspection
Polypeptide Laboratories FrancePolypeptide Laboratories France – FDA Inspection, Jul 4, 2024
Record Details
This FDA Inspection record concerns Polypeptide Laboratories France, with an inspection on July 4, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e18fc9be-2980-4e11-a3ef-554bf9e25eeb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1280973
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Polypeptide Laboratories France
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Polypeptide Laboratories France
- FDA Inspection 1107059 - 2019-09-12
- FDA Inspection 884800 - 2014-05-23
- FDA Inspection 620930 - 2009-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.